showed a trendp = 0.069
The 12 mg/m 2 dose reduced the number of T2‐weighted lesions at month 24 ( p = 0.027) and showed a trend at month 12 ( p = 0.069).
The 12 mg/m 2 dose reduced the number of T2‐weighted lesions at month 24 ( p = 0.027) and showed a trend at month 12 ( p = 0.069).